Chan, Terence Ho Wah 陳浩華
|1||*||China Regenerative Medicine International Limited||INEDIndependent Non-Executive Director||2007-07-16||2008-06-23||-48.86%||-51.04%||-52.06%|
|2||*||Chinese Strategic Holdings Limited||INEDIndependent Non-Executive Director||2005-08-12||2008-10-27||330.38%||58.46%||51.02%|
|3||HKSAR Security and Guarding Services Industry Authority||MemberMember||2017-06-01||2021-06-01|
|4||HKSAR Witness Protection Review Board Panel||MemberMember||2019-01-01||2021-01-01|
|5||HONG KONG BAPTIST UNIVERSITY||CouncillorCouncillor||2016-01-01||2022-01-01|
|6||Hong Kong Independent Non-Executive Director Association Limited (The)||VP, CouncilVice President, Council|
|7||HSL Capital Limited||CEOChief Executive Officer|
|8||*||Ruixin International Holdings Limited||INEDIndependent Non-Executive Director||2003-11-13||2004-01-02||40.00%|
|9||SFC Committee on Real Estate Investment Trusts||MemberMember||2017-04-01||2020-04-01|
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed